Gerard Bittner

547 total citations
18 papers, 446 citations indexed

About

Gerard Bittner is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Gerard Bittner has authored 18 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Gerard Bittner's work include Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and interferon and immune responses (3 papers). Gerard Bittner is often cited by papers focused on Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and interferon and immune responses (3 papers). Gerard Bittner collaborates with scholars based in United States. Gerard Bittner's co-authors include Joan H. Schiller, James K. V. Willson, Lorraine F. Meisner, Terry D. Oberley, James L. Weese, Paul H. Fischer, Rifat Pamukcu, Ernest C. Borden, William H. Wolberg and Michael Hawkins and has published in prestigious journals such as International Journal of Cancer, International Journal of Oncology and Oncology.

In The Last Decade

Gerard Bittner

18 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerard Bittner United States 10 220 177 93 91 83 18 446
Kyoichiro Higashi Japan 11 399 1.8× 110 0.6× 65 0.7× 115 1.3× 63 0.8× 15 628
Ugo Consoli United States 10 271 1.2× 199 1.1× 64 0.7× 105 1.2× 61 0.7× 15 550
Vicente Fresquet Spain 16 442 2.0× 166 0.9× 132 1.4× 105 1.2× 37 0.4× 24 703
Neil Kernohan United Kingdom 11 244 1.1× 210 1.2× 115 1.2× 49 0.5× 60 0.7× 22 528
Christine White Australia 10 218 1.0× 131 0.7× 81 0.9× 74 0.8× 49 0.6× 17 433
Arthur T. Hoang United States 10 520 2.4× 241 1.4× 63 0.7× 85 0.9× 73 0.9× 11 700
W-D Ludwig Germany 13 397 1.8× 190 1.1× 125 1.3× 148 1.6× 79 1.0× 13 756
Amanda L. Boehm United States 6 259 1.2× 268 1.5× 78 0.8× 133 1.5× 59 0.7× 7 498
S Zinn United States 11 533 2.4× 445 2.5× 85 0.9× 112 1.2× 72 0.9× 14 885
MV Blagosklonny United States 9 547 2.5× 185 1.0× 34 0.4× 112 1.2× 66 0.8× 9 773

Countries citing papers authored by Gerard Bittner

Since Specialization
Citations

This map shows the geographic impact of Gerard Bittner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Bittner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Bittner more than expected).

Fields of papers citing papers by Gerard Bittner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard Bittner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Bittner. The network helps show where Gerard Bittner may publish in the future.

Co-authorship network of co-authors of Gerard Bittner

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard Bittner. A scholar is included among the top collaborators of Gerard Bittner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard Bittner. Gerard Bittner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abhyankar, Vinay V., et al.. (2003). HUMAN EMBRYONIC STEM CELL CULTURE IN MICROFLUIDIC CHANNELS. 3 indexed citations
2.
Schiller, Joan H. & Gerard Bittner. (1999). Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.. PubMed. 5(12). 4287–94. 58 indexed citations
3.
Schiller, Joan H., Gerard Bittner, Shiqi Wu, & Lorraine F. Meisner. (1998). Karyotypic changes associated with spontaneous acquisition and loss of tumorigenicity in a human transformed bronchial epithelial cell line: Evidence for In vivo selection of transformed clones. In Vitro Cellular & Developmental Biology - Animal. 34(4). 283–289. 6 indexed citations
5.
Sabatini, Linda M., et al.. (1994). PHENOTYPIC, MOLECULAR AND GENETIC-CHARACTERIZATION OF TRANSFORMED HUMAN BRONCHIAL EPITHELIAL-CELL STRAINS. International Journal of Oncology. 4(2). 461–70. 8 indexed citations
6.
Schiller, Joan H., Gerard Bittner, & David R. Spriggs. (1992). Tumor necrosis factor, but not other hematopoietic growth factors, prolongs the survival of hairy cell leukemia cells. Leukemia Research. 16(4). 337–346. 10 indexed citations
7.
Schiller, Joan H., Gerard Bittner, Lorraine F. Meisner, et al.. (1991). Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient.. PubMed. 5(5). 399–407. 9 indexed citations
8.
Schiller, Joan H., Barry E. Storer, Gerard Bittner, & Michel A. Horisberger. (1990). Characterization of the Synergistic Antiproliferative Effects of Interferon-γ and Tumor Necrosis Factor on Human Colon Carcinoma Cell Lines. Journal of Interferon Research. 10(2). 129–139. 8 indexed citations
9.
Schiller, Joan H. & Gerard Bittner. (1990). Anti‐proliferative effects of tumor necrosis factor, gamma interferon and 5‐fluorouracil on human colorectal carcinoma cell lines. International Journal of Cancer. 46(1). 61–66. 18 indexed citations
10.
Schiller, Joan H., Michel A. Horisberger, Gerard Bittner, et al.. (1990). Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.. PubMed. 9(4). 368–77. 4 indexed citations
11.
Schiller, Joan H., et al.. (1987). Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.. PubMed. 47(11). 2809–13. 60 indexed citations
12.
Willson, James K. V., Gerard Bittner, Terry D. Oberley, Lorraine F. Meisner, & James L. Weese. (1987). Cell culture of human colon adenomas and carcinomas.. PubMed. 47(10). 2704–13. 122 indexed citations
13.
Schiller, Joan H., James K. V. Willson, Gerard Bittner, et al.. (1986). Antiproliferative Effects of Interferons on Human Melanoma Cells in the Human Tumor Colony-Forming Assay. Journal of Interferon Research. 6(6). 615–625. 36 indexed citations
14.
Willson, James K. V., Gerard Bittner, Terry D. Oberley, & James L. Weese. (1985). Primary and continuous culture of human colonic adenomas, carcinomas, and metastases. 1 indexed citations
15.
Willson, James K. V., Gerard Bittner, & Ernest C. Borden. (1984). Antiproliferative Activity of Human Interferons Against Ovarian Cancer Cells Grown in Human Tumor Stem Cell Assay. Journal of Interferon Research. 4(4). 441–447. 16 indexed citations
16.
Fischer, Paul H., Rifat Pamukcu, Gerard Bittner, & James K. V. Willson. (1984). Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.. PubMed. 44(8). 3355–9. 54 indexed citations
17.
VandeBerg, John L., et al.. (1982). Biochemical genetics of macaques. III. Inheritance of carbonic anhydrase II polymorphism in rhesus monkeys. Biochemical Genetics. 20(5-6). 437–441. 6 indexed citations
18.
VandeBerg, John L., et al.. (1981). LINKAGE OF NEURAMINIDASE AND α‐MANNOSIDASE TO THE MAJOR HISTOCOMPATIBILITY COMPLEX IN THE RAT. International Journal of Immunogenetics. 8(3). 239–242. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026